Publications

5808 Results

Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases: SWOG S0702, NCT00874211

Authors
C Van Poznak;J Unger;A Darke;C Moinpour;R Bagramian;L Hansen;J Floyd;S Dakhil;D Lew;J Wade;M Fisch;NL Henry;D Hershman;J Gralow
Journal / Conference
J Clin Oncol 37 (suppl; abstr 11502);ASCO Annual Meeting (May 31-June 4, 2019, Chicago, IL), oral
Year
2019
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S0702

S1206: A Dose-Finding Study followed by a Phase II Randomized, Placebo-Controlled Trial of Chemoradiotherapy (CRT) with or without Veliparib in Stage III Non-Small Cell Lung Cancer (NSCLC)

Authors
A Argiris;J Miao;M Cristea;AM Chen;J Sands;RH Decker;S Gettinger;M Daly;BA Faller;KS Albain;R Yanagihara;LL Garland;L Byers;D Wang;M Koczywas;M Redman;K Kelly;D Gandrara
Journal / Conference
J Clin Oncol 37, 2019 (suppl; abstr 552); ASCO Annual Meeting (May 31-June 4, 2019, Chicago, IL), poster session
Year
2019
Research Committee(s)
Lung
Study Number(s)
S1206 (8811)

SWOG S1314: A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer

Authors
T Flaig;C Tangen;S Daneshmand;A Alva;MS Lucia;D McConkey;D Theodorescu;A Goldkorn;M Milowsky;R Bangs;G MacVicar;BR Bastos;D Gustafson;M Plets;IM Thompson
Journal / Conference
J Clin Oncol 37(suppl; abstr 4506); ASCO Annual Meeting (May 31-June 4, 2019, Chicago, IL), oral
Year
2019
Research Committee(s)
Genitourinary
Study Number(s)
S1314

Randomized Trial of Text-Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women with Early Stage Breast Cancer: SWOG S1105, NCT01515800

Authors
D Hershman;J Unger;G Clarke Hillyer;A Moseley;K Arnold;S Dakhil;B Esparaz;M Kuan;ML Graham;D Lackowski;W Edenfield;Z Dayao;J Gralow;S Ramsey;A Neugut
Journal / Conference
J Clin Oncol 37(suppl; abstr 6516); American Society of Clinical Oncology (5/31/2019 - 6/4/2019, Chicago IL), oral
Year
2019
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1105

A Phase II Study of Talazoparib (BMN 673) in Patients with Homologous Recombination Repair Deficiency (HRRD) Positive Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub- Study, S1400G)

Authors
T Owonikoko;M Redman;L Byers;F Hirsch;P Mack;L Schwartz;J Bradley;T Stinchcombe;N Leighl;T Al Baghdadi;P Lara;J Miao;K Kelly;S Ramalingam;R Herbst;V Papadimitrakopoulou;D Gandara
Journal / Conference
J Clin Oncol 37(suppl; abstr 9022); ASCO (5/31/2019-6/4/2019, Chicago IL), poster discussion
Year
2019
Research Committee(s)
Lung
Study Number(s)
S1400G

Phase II study of ABBV-399 (Process II) in patients with C-MET positive stage IV/recurrent lung squamous cell cancer (SCC): LUNG-MAP sub-study S1400K (NCT03574753)

Authors
S Waqar;M Redman;S Arnold;FR Hirsch;PC Mack;L Schwartz;D Gandara;T Stinchcombe;N Leighl;S Ramalingam;S Tanna;R Raddin;K Minichiello;K Kelly;J Bradley;R Herbst;V Papadimitrakopoulou
Journal / Conference
J Clin Oncol 37(suppl; abstr 9075); American Society of Clinical Oncology (5/31/19-6/4/19, Chicago IL), poster session
Year
2019
Research Committee(s)
Lung
Study Number(s)
S1400K

A phase III randomized study of nivolumab plus ipilimumab versus nivolumab for previously treated patients with stage IV squamous cell lung cancer and no matching biomarker (Lung-MAP Sub-Study S1400I, NCT02785952).

Authors
L Bazhenova;M Redman;S Gettinger;F Hirsch;PC Mack;L Schwartz;D Gandara;J Bradley;T Stinchcombe;N Leighl;S Ramalingam;S Tavernier;K Minichiello;K Kelly;V Papadimitrakopoulou;R Herbst
Journal / Conference
J Clin Oncol 37(suppl; abstr 9014); ASCO (5/31/19-6/4/19, Chicago IL), poster discussion
Year
2019
Research Committee(s)
Lung
Study Number(s)
S1400I

Design and Accrual of SWOG S1417CD: Development of a Prospective Financial Impact Assessment Tool in Patients with Metastatic Colorectal Cancer (mCRC)

Authors
V Shankaran;J Unger;A Darke;JM Suga;JL Wade;P Kourlas;S Chandana;M O'Rourke;S Satti;D Liggett;D Hershman;S Ramsey
Journal / Conference
J Clin Oncol 37(suppl; abstr TPS6652); American Society of Clinical Oncology (5/31/19-6/4/19, Chicago IL), TIPS, poster session
Year
2019
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1417CD

S1507: Phase II study of docetaxel and trametinib in patients with G12C or non-G12C KRAS mutation positive (+) recurrent non-small cell lung cancer (NSCLC)

Authors
S Gadgeel;J Miao;J Riess;PC Mack;G Gerstner;TF Burns;A Taj;W Akerley;K Dragnev;J Moon;D Gandara;K Kelly
Journal / Conference
J Clin Oncol 37(suppl; abstr 9021); American Society of Clinical Oncology (5/31/19-6/4/19, Chicago IL), poster discussion
Year
2019
Research Committee(s)
Lung
Study Number(s)
S1507

SWOG S1505: Initial Findings on Eligibility and Neoadjuvant Chemotherapy Experience with mFOLFIRINOX versus Gemcitabine/nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

Authors
D Sohal;D Lew;S Ahmad;N Gandhi;S Beg;A Wang-Gillam;J Wade;K Guthrie;A Lowy;P Philip;H Hochster
Journal / Conference
J Clin Oncol 37(suppl; abstr 4137); American Society of Clinical Oncology (5/31/19 - 6/4/19, Chicago IL), poster session
Year
2019
Research Committee(s)
Gastrointestinal
Study Number(s)
S1505